Credit Suisse’s Genesis Healthcare, Inc. GEN Stock Holding History
Bought
Maintained
Sold
Other funds holding GEN
VCM
FWC
PAM
Credit Suisse's GEN Position: Q4 2019 in Review
Credit Suisse sold out of Genesis Healthcare, Inc. (GEN) in Q4 2019, closing a stake of 19,884 shares — an estimated $22K sold.
Credit Suisse first reported a position in GEN in Q2 2015 and held it in 16 quarters. The position peaked at $143K in Q4 2016. 69 funds tracked by Wall St. Rank hold GEN as of Q4 2019.
- Credit Suisse reported no remaining Genesis Healthcare, Inc. position as of Q4 2019 after selling out during the quarter.
- Credit Suisse sold 19,884 Genesis Healthcare, Inc. shares in Q4 2019, an estimated $22K.
- Credit Suisse first reported a position in Genesis Healthcare, Inc. in Q2 2015 and held it in 16 quarters.
- Credit Suisse's Genesis Healthcare, Inc. position peaked at $143K in Q4 2016.
- 69 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2019.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.